MindWalk Holdings Corp. (HYFT)

Market Cap	85.39M
Revenue (ttm)	17.74M
Net Income (ttm)	-21.88M
Shares Out	46.15M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	768,604
Open	1.920
Previous Close	1.940
Day's Range	1.850 - 2.000
52-Week Range	0.270 - 3.246
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2025

About HYFT

MindWalk Holdings Corp. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jan 3, 2017
• Employees: 102
• Stock Exchange: NASDAQ
• Ticker Symbol: HYFT
• Website: https://www.ipatherapeutics.com

Financial Performance

In 2025, MindWalk Holdings's revenue was 24.52 million, an increase of 0.01% compared to the previous year's 24.52 million. Losses were -30.23 million, 15.8% more than in 2024.

Financial numbers in CAD